Next Article in Journal
Vitamin D Status of Severe COPD Patients with Chronic Respiratory Failure
Previous Article in Journal
Consensus Statement on a Screening Programme for the Detection of Early Lung Cancer in Poland
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence and Predictors of Readmissions among Adults with Cystic Fibrosis in the United States

by
Kshitij Chatterjee
1,*,
Abhinav Goyal
2,
Deepak Reddy
1,
Vikas Koppurapu
1,
Ayoub Innabi
1,
Bashar Alzghoul
1 and
Rajani Jagana
1
1
University of Arkansas for Medical Sciences, Little Rock, AR, USA
2
Einstein Medical Center, Philadelphia, PA, USA
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2018, 86(2), 75-77; https://doi.org/10.5603/ARM.2018.0006
Submission received: 30 December 2017 / Revised: 24 February 2018 / Accepted: 24 February 2018 / Published: 30 April 2018

Abstract

Introduction: Patients with Cystic Fibrosis (CF) have increasing rates of hospitalization. We analyzed the burden and predictors of thirty-day readmission among patients with CF in the U.S. Material and methods: Nationwide Readmission Database (NRD) 2013 was used to identify adults with CF who were hospitalized. These individuals were followed to determine the prevalence of readmission within thirty days of index discharge. Cox proportional hazard regression was used to identify independent predictors of readmission. Results: There were 14,616 index admissions of adults with CF in 2013. Of these, 2606 (17.8%) patients were readmitted within 30 days of discharge. Female sex and chronic anemia were independent predictors of readmission. The most common causes of readmission were pulmonary exacerbation (31%), lung transplant complications (5.2%), and septicemia (3.4%). Conclusion: Readmissions are frequent among adults with CF and contribute to significant healthcare burden and cost among this population.
Keywords: cystic fibrosis; readmissions; epidemiology cystic fibrosis; readmissions; epidemiology

Share and Cite

MDPI and ACS Style

Chatterjee, K.; Goyal, A.; Reddy, D.; Koppurapu, V.; Innabi, A.; Alzghoul, B.; Jagana, R. Prevalence and Predictors of Readmissions among Adults with Cystic Fibrosis in the United States. Adv. Respir. Med. 2018, 86, 75-77. https://doi.org/10.5603/ARM.2018.0006

AMA Style

Chatterjee K, Goyal A, Reddy D, Koppurapu V, Innabi A, Alzghoul B, Jagana R. Prevalence and Predictors of Readmissions among Adults with Cystic Fibrosis in the United States. Advances in Respiratory Medicine. 2018; 86(2):75-77. https://doi.org/10.5603/ARM.2018.0006

Chicago/Turabian Style

Chatterjee, Kshitij, Abhinav Goyal, Deepak Reddy, Vikas Koppurapu, Ayoub Innabi, Bashar Alzghoul, and Rajani Jagana. 2018. "Prevalence and Predictors of Readmissions among Adults with Cystic Fibrosis in the United States" Advances in Respiratory Medicine 86, no. 2: 75-77. https://doi.org/10.5603/ARM.2018.0006

Article Metrics

Back to TopTop